FDA Adverse Event
Injury
Summary report: N
RELIZORB
MDR report key: 25303317
·
Received May 27, 2026
Report
- Report Number
- MW5188657
- Event Type
- Injury
- Date Received
- May 27, 2026
- Date of Event
- May 10, 2026
- Report Date
- May 21, 2026
- Manufacturer
- ALCRESTA THERAPEUTICS, INC.
- Product Code
- PLQ
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- PHARMACIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT WAS HOSPITALIZED FOR HIGH BLOOD SUGAR FROM MAY 10-12 AND WAS DIAGNOSED WITH DIABETES. THEY ARE STILL TAKING RELIZORB WITH NO CHANGES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 248090 | RELIZORB | ENZYME PACKED CARTRIDGE | PLQ | ALCRESTA THERAPEUTICS, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Male | Hospitalization |